Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pech

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Gastrointestinal Endoscopy|June 4, 2017
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
The American Journal of Gastroenterology|June 2, 2017
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
Gastrointestinal Endoscopy|April 18, 2024
Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists (with video)Jelmer B Jukema, Carolus H J Kusters, Martijn R Jong, et al.
Cancer Medicine|January 20, 2016
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskJessica Becker, Andrea May, Christian Gerges, et al.
Cancer Medicine|September 19, 2015
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaJessica Becker, Andrea May, Christian Gerges, et al.
The American Journal of Gastroenterology|April 15, 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
The American Journal of Gastroenterology|June 9, 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
Gut|January 5, 2018
Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complicationsAngelika Behrens, Anton Kreuzmayr, Hendrik Manner, et al.
Cancer Medicine|September 8, 2018
Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome levelSophie K M Heinrichs, Timo Hess, Jessica Becker, et al.
The Lancet. Oncology|August 17, 2016
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysisPuya Gharahkhani, Rebecca C Fitzgerald, Thomas L Vaughan, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Gastrointestinal Endoscopy|June 4, 2017
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
The American Journal of Gastroenterology|June 2, 2017
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) ConsortiumSachin Wani, V Raman Muthusamy, Nicholas J Shaheen, et al.
Gastrointestinal Endoscopy|April 18, 2024
Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists (with video)Jelmer B Jukema, Carolus H J Kusters, Martijn R Jong, et al.
Cancer Medicine|January 20, 2016
The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma riskJessica Becker, Andrea May, Christian Gerges, et al.
Cancer Medicine|September 19, 2015
Supportive evidence for FOXP1, BARX1, and FOXF1 as genetic risk loci for the development of esophageal adenocarcinomaJessica Becker, Andrea May, Christian Gerges, et al.
The American Journal of Gastroenterology|April 15, 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
The American Journal of Gastroenterology|June 9, 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade DysplasiaCathy Bennett, Paul Moayyedi, Douglas A Corley, et al.
Gut|January 5, 2018
Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complicationsAngelika Behrens, Anton Kreuzmayr, Hendrik Manner, et al.
Cancer Medicine|September 8, 2018
Evidence for PTGER4, PSCA, and MBOAT7 as risk genes for gastric cancer on the genome and transcriptome levelSophie K M Heinrichs, Timo Hess, Jessica Becker, et al.
The Lancet. Oncology|August 17, 2016
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysisPuya Gharahkhani, Rebecca C Fitzgerald, Thomas L Vaughan, et al.
Pageof 16